Efgartigimod + Telitacicept (1-week interval) group
KY2024-298
Unknown small_molecule active
Quick answer
Efgartigimod + Telitacicept (1-week interval) group for Myasthenia Gravis is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Myasthenia Gravis
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active